Home/Filings/4/0000899243-21-031086
4//SEC Filing

Caffo Nathan 4

Accession 0000899243-21-031086

CIK 0001841387other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 8:02 PM ET

Size

9.3 KB

Accession

0000899243-21-031086

Insider Transaction Report

Form 4
Period: 2021-07-29
Caffo Nathan
Chief Business Officer
Transactions
  • Purchase

    Common Stock

    2021-07-29$8.00/sh+6,000$48,0006,000 total

Issuer

Candel Therapeutics, Inc.

CIK 0001841387

Entity typeother

Related Parties

1
  • filerCIK 0001816992

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 8:02 PM ET
Size
9.3 KB